Recent News

• 02.12.2026 - Pacira to Report 2025 Financial Results on Thursday February 26, 2026
• 02.12.2026 - Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices
• 02.09.2026 - Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 01.28.2026 - Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors
• 01.13.2026 - Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets
• 01.08.2026 - Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues

Recent Filings

• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 01.29.2026 - 3 Initial statement of beneficial ownership of securities
• 01.29.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.28.2026 - 8-K Current report